Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 11, 2007, Pages 1877-1881

  Rubio, Carlos A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carcinoma; Colon; Invasion; Proliferation

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; CELL CYCLE G0 PHASE; CELL INVASION; CELL PROLIFERATION; COLON ADENOCARCINOMA; GENE MUTATION; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 34948867333     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04839.x     Document Type: Article

References (29)

1. Newland R, Dent R, Lyttle N, Chapuis P, Bokey E. Pathological determinants of survival associated with colorectal cancer. Cancer 1993 73 : 2076 82.
2. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor 'budding' in patients with colorectal cancer. Dis. Colon Rectum. 1993 36 : 627 35.
3. MacCarry WG. Principles of prognosis in cancer. JAMA 1931 96 : 30 3.
4. Wells A. Tumor invasion: role of growth factor-induced cell motility. In : Van de Woude G, Klein G, eds. Advances in Cancer Research, Vol 78. San Diego : Academic Press, 2000 31 99.
5. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer. Rev. 2003 3 : 362 74.
6. Choi H, Jung I, Kim S, Hong S. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas. Dis. Colon Rectum. 1997 40 : 51 9.
7. Salminen E, Palmu S, Vahlberg T, Roberts PJ, Soderstrom KO. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J. Gastroenterol. 2005 11 : 3245 9.
8. Yang JL, Ow KT, Russell PJ, Ham JM, Crowe PJ. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann. Surg. Oncol. 1996 3 : 574 9.
9. Mehta K, Goldfarb M, Zinterhofer L. Absent p53 protein in colorectal tumor cells reflects poor survival. J. Appl. Res. Clin. Experiment Ther. 2002 2 : 234 54.
10. Cristi E, Perrone G, Toscano G et al. Tumour proliferation, angiogenesis, and ploidy status in human colon cancer. J. Clin. Pathol. 2005 58 : 1170 4.
11. Kanamaru T, Tanaka K, Kotani J et al. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer. Int. J. Mol. Med. 2002 10 : 205 10.
12. Malhotra S, Newman E, Eisenberg D et al. Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: a possible mechanism of neoplastic progression. Dis. Colon Rectum. 2002 45 : 537 43.
13. Rubio CA. Colorectal carcinomas. Possible mechanism of local tumor progression. Anticancer Res. 2003 23 : 347 50.
14. Rubio CA. Further studies on the histological characteristics linked to local tumour invasion in colorectal carcinomas. Anticancer Res. 2003 23 : 3555 60.
15. Rubio CA, Lindhblom A. Histological changes pertinent to local tumor progression in Hereditary Nonpolyposis Colorectal Cancer (HNPCC). Anticancer Res. 2004 24 : 1765 8.
16. Rubio CA. Adenocarcinoma in inflammatory colorectal disease. Histologic features pertinent to local tumour progression. Anticancer Res. 2003 23 : 4313 18.
17. Rubio CA. Possible mechanism of local tumor progression in experimentally induced colorectal carcinomas in rats. In Vivo 2003 17 : 97 100.
18. Rubio CA. Possible mechanism connected with the progression of submucosal invasion in colorectal neoplasias. Anticancer Res. 2005 25 : 2503 8.
19. Rubio CA. Colorectal cancer. A tumour with open borders. Adv. Clin. Exp. Med. 2005 14 : 863 7.
20. Rubio CA, Lagergren J. Histological features pertinent to local tumour progression in Barrett's adenocarcinoma. Anticancer Res. 2003 23 : 3015 18.
21. Rubio CA. Cell proliferation at the invading leading front of colonic carcinomas: Preliminary observations. Anticancer Res. 2006 26 : 2275 8.
22. Foijer F, Wolthuis R, Doodeman V, Medema R, Riele H. Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 2005 8 : 455 64.
23. Rubio CA. Tumor cells induce apoptosis in lymphocytes. Nat. Med. 1997 3 : 253 4.
24. Rubio CA. Apoptosis versus polemosis. Different mechanisms leading to nonnecrotic cell death. Anticancer Res. 2006 26 : 183 6.
25. Kroemer G, Jäätela M. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 2005 5 : 886 97.
26. Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat. Rev. Cancer 2006 6 : 99 106.
27. Itoh Y, Joh T, Tanida S et al. IL-8 promotes cell proliferation and migration through metalloproteinase- cleavage proHB-EGF in human colon carcinoma cells. Cytokine 2005 29 : 275 82.
28. Bukholm IK, Nesland JM. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch. 2000 436 : 224 8.
29. Doglioni C, Pelosio P, Laurino L et al. p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J. Pathol. 1996 179 : 248 53.